Skip to main content
A Lazaro Cebas on Muck Rack

A Lazaro Cebas

As seen in: European Journal of Hospital Pharmacy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with A Lazaro

Contact A Lazaro, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

CP-037 Use of sofosbuvir in hepatitis C

|
By M Nieves Sedano, I Gomez, D Alioto, A Lazaro Cebas
| European Journal of Hospital Pharmacy Verified
Background Hepatitis C is a serious disease with a high prevalence, being the leading cause of liver transplantation. There is now rapid development of new drugs for this disease. During the period of this study, only the following anti-hepatitis C agents were available: peg-interferon, telaprevir, boceprevir, simeprevir, sofosbuvir daclatasvir and ribavirin.
Open in Who Shared Issue with article?
See all 1 articles